CN101818129B - Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby - Google Patents
Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby Download PDFInfo
- Publication number
- CN101818129B CN101818129B CN201010154062XA CN201010154062A CN101818129B CN 101818129 B CN101818129 B CN 101818129B CN 201010154062X A CN201010154062X A CN 201010154062XA CN 201010154062 A CN201010154062 A CN 201010154062A CN 101818129 B CN101818129 B CN 101818129B
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- swine fever
- african swine
- fever virus
- cell line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a hybridoma cell line for an anti-African swine fever virus structural protein P54 monoclonal antibody, a method for establishing the monoclonal antibody and application of the monoclonal antibody. The hybridoma cell line is mainly characterized in that: a recombinant P54 soluble antigen is prepared by prokaryotic expression, and BALB/c immune mouse is fused, sifted and cloned by using a hybridoma technique to obtain the hybridoma cell line capable of stably secreting the anti-African swine fever virus structural protein P54 monoclonal antibody. The invention also discloses preparation of the monoclonal antibody by using the cell line, a method for purifying the antibody and a horseradish peroxidase labeling method for the antibody. The monoclonal antibody can be used for detecting an African swine fever virus antibody in pig serum.
Description
Technical field
The invention belongs to biotechnology and cell engineering field, relate to secretion anti-African swine fever virus monoclonal antibody hybridoma cell line and excretory monoclonal antibody thereof, and described Purification of Monoclonal Antibodies, mark and application, particularly detect the application of African swine fever virus in the porcine blood serum.
Background technology
(African swine fever ASF) is a kind of acute, hot, the strong communicable disease of contact highly of the pig that caused by African swine fever virus (ASFV) to African swine fever.It is characterized by course of disease weak point, case fatality rate high rate, can be up to 100%, clinical symptom and pathological change all are similar to acute swine fever, very easily mistaken diagnosis when diagnosis, the high heat of performance, dermohemia cyanosis, miscarriage, oedema and internal organs are hemorrhage.(William, Hess Adv.African swine fever:a reassessment[J] .Vet Sci Comp Med, 1981,25:39～69) world animal tissues (OIE) classifies the category-A eqpidemic disease as, China is defined as animal one class disease, be subjected to countries in the world great attention (Sun Huaichang. Chinese Preventive Veterinary Medicine newspaper, 1999,21 (2): 117～119).
This disease from nineteen twenty-one since Kenya finds, be present in the African country on the south the Sahara always, nineteen fifty-seven successively spreads to West Europe and Latin American countries, majority is in time put out, singly in Portugal, the Spain west and south and gondola Sardinia still have popular, and be popular in dozens of countries such as Africa, Europe and America so far, and continuous spreading trend is arranged.2007, Armenia recurred six African swine fevers, and China does not still have this disease.
African swine fever belongs to Iridoviridae in the 4th report of ICTV, in the 5th report of this council it is listed under the Poxviridae, places outside the Chordopoxvirinae and Entomopoxvirinae of this section.But dna sequence analysis shows, ASF virus has the feature between poxvirus and irido virus, this characteristic of ASFV shows any section that it does not belong to ICTV and is appraised and decided, be individual new, the 6th report of nineteen ninety-five the 9th international virus taxis committee member, African swine fever virus is listed in " class African swine fever virus genus ", African swine fever is unique known representative species.
African swine fever virus is a kind of big, double-stranded DNA virus that cyst membrane is arranged, is unique entomophila dna virus.Its genome is terminal covalence closed unit molecule wire double-stranded DNA, the viral genome total length is 170kb～190kb, there is the conserved regions about 125kb in central authorities, two ends are the variable region, contain terminal counter-rotating tumor-necrosis factor glycoproteins, the increase of these tumor-necrosis factor glycoproteinss or disappearance are to cause the major cause (Rafacl of different isolates genome difference in length, Yancz, Javier M, et al.Analysis of the completeNucleotide Sequence of Afican Swine Fever Virus[J] .Virology, 1995,208:249～279).The ASF viral genome has 5 encoding genes, comprise putative membrane protein, secreted protein, participation nucleic acid and nucleic acid metabolism (DNA reparation) and protein modified enzyme, whole genome contains 151 ORF, 150～200 kinds of protein of can encoding, isolation identification goes out 86 kinds of viral protein polypeptide (Qu Liandong, Yu Kangzhen from the cell that ASFV infects, the African swine fever progress, China animal doctor science and technology, 1998,28 (11): 42～43).
The virulence of the most of strains of African swine fever virus is all very strong, but immunogenicity is very low, has only a few albumen to have immunogenicity, and wherein P54 albumen is for having one of better antigenic albumen.
ASFV P54 albumen is by the E183L genes encoding, and the polypeptide of about 25kD contains one section and strides diaphragm area, mainly concentrates on deutero-endoplasmic reticulum place.P54 albumen can be in vitro culture, and can cells infected.And behind cells infected at endoplasmic reticulum place transient expression.The proteic membrane structure of striding of P54 plays crucial effect (RodriguezJM at viral protein when endoplasmic reticulum changes into the peplos precursor, Garcia Escudero African Swine Fever Virus Structural Protein p54 IsEssential for the Recruitment of Envelope Precursors to Assembly Sites.Journalof Virology, 2004,78 (8): 4299～4313).There is special cross reaction in the light chain tenuigenin dynein DLC8 of ASFV P54 albumen and 8kD in addition, and plays an important role in the endocytosis and the viral course of processing.Duplicate early stage behind the infective virus, but virus activating cells apoptotic proteins enzyme and bring out cell apoptosis (Alonso C, J Miskin African Swine Fever Virus Protein p54Interacts with the Microtubular Motor Complex through Direct Binding toLight-Chain Dynein.Journal of Virology 2001,75:9819～9827).For taking off at cell, analytical structure albumen P54 bites middle role, Hernaez B in 2004 and Diaz-Gil G are with its transient expression in African green monkey kidney cell, but experiment shows activating cells apoptotic proteins enzyme, bring out cell apoptosis (Hernaez B, Diaz Gil G.The African swine fever virusdynein-binding protein p54 induces infected cell apoptosis.FEBS Letters2004,569 (123): 224～228).
Summary of the invention
The purpose of this invention is to provide a kind of hybridoma cell line of secreting the monoclonal antibody of specific recognition African swine fever virus.Another object of the present invention provides above-mentioned clone excretory anti-African swine fever virus monoclonal antibody, and described monoclonal antibody has specificity preferably to African swine fever structural protein P54 antigen.Another object of the present invention provides the enzyme labelling thing of above-mentioned purifying antibody and horseradish peroxidase.
In order to solve the problems of the technologies described above, the technical solution used in the present invention is: a kind of hybridoma cell line of anti-African swine fever virus monoclonal antibody, the preserving number of described clone are CGMCCNO.3750.
Described hybridoma cell line is set up as immunogen with prokaryotic expression recombinant soluble proteins P54 by hybridoma technology.
Described hybridoma cell line excretory anti-African swine fever virus monoclonal antibody.
Described monoclonal antibody purifying is after the sodium periodate legal system is equipped with the enzyme labelling thing of horseradish peroxidase.
Beneficial effect of the present invention: hybridoma cell strain ASFV:P54Mab and excretory monoclonal antibody thereof that this invention is prepared can be discerned the ASFV natural antigen, the monoclonal antibody that is obtained is not only in the ASFV fundamental research, and all has very high using value in the immunoreactive detection reagent of ASFV antigen-antibody.
Description of drawings
Fig. 1 is SDS-PAGE figure behind the reorganization P54 protein purification.
Fig. 2 is western blotting figure behind the reorganization P54 protein purification.
Fig. 3 detects sample African swine fever antibody lab diagram for adopting ELISA test kit of the present invention.
Embodiment
The hybridoma cell line of anti-African swine fever virus monoclonal antibody is preserved in the common micro-organisms center C GMCC NO.3750 of China Committee for Culture Collection of Microorganisms, preservation day: 2010-04-22, classification name: hybridoma cell strain.
Below in conjunction with embodiment the present invention is described in further detail:
Technical scheme of the present invention is as follows:
One, sets up clone
1. antigen prepd
A) the proteic expression of African swine fever P54
According to African swine fever among the GenBank (ASFV) P54 gene order, 1 pair of primer has been synthesized in design, adopt PCR method from ASFV DNA, to amplify the P54 gene fragment, it is cloned among the expression vector pET28b, made up recombinant plasmid pET-P54, be transformed into expressive host bacterium BL21 (DE3) after the sequence verification, through the IPTG abduction delivering.
The primer of design is:
P54-1-5’-GC
GGATCCCATTATTATCATCGTT-3’
P54-2-5’-AG
CTCGAGCAAGGAGTTTTCTA-3’
Underscore is the restriction enzyme site for introducing partly, and P54-1 is an ASFV P54 upstream region of gene amplimer, and the restriction enzyme site of introducing is BamHI; P54-2 is an ASFV P54 gene downstream amplimer, and the restriction enzyme site of introducing is XhoI.
B) the proteic purifying of African swine fever P54.
After inducing end, the back thalline is induced in centrifugal collection, washs resuspended thalline with PBS, ultrasonic degradation (ultrasonic 1s, 1s, 10min altogether at interval), and 12000rpm is centrifugal, collects respectively and goes up cleer and peaceful precipitation, carries out SDS-PAGE and analyzes.Use the nickel ion affinity chromatograph post during protein purification, behind the purifying, identify, get access to single band, and possess antigenicity (seeing accompanying drawing 1,2) preferably through SDS-PAGE, western blotting.Protein content behind the use BCA method mensuration purifying, standard substance concentration and corresponding OD value thereof see Table 1.The proteic OD value of P54 is 1.583 behind the purifying, with standard substance relatively after, its concentration is 900 μ g/ml.
Table 1BCA method bioassay standard product protein content
| Bar product title | A (μg/ml) | B (μg/ml) | C (μg/ml) | D (μg/ml) | E (μg/ml) | F (μg/ml) | G (μg/ml) | H (μg/ml) | 0 (μg/ml) |
| Concentration | 2000 | 1500 | 1000 | 750 | 500 | 250 | 125 | 25 | 0 |
| The OD value | 2.6894 | 2.2378 | 1.6493 | 1.3278 | 1.0414 | 0.6454 | 0.4062 | 0.1893 | 0.1251 |
2. antigen immune
African swine fever virus P54 albumen with purifying is antigen, ordinary method immunity BALB/c mouse in 6 age in week, and the antigen of fundamental immunity subcutaneous injection first 200 μ g use complete Freund's adjuvant; Immune every carrying out in 3 weeks once, totally three times, 50 μ g//times, intrasplenic injection booster immunizations after 3 weeks after the last fundamental immunity, 25 μ g/, immunity is finished.
3. the preparation of hybridoma
A) preparation of feeder cell
With the BALB/c mouse peritoneal macrophage as feeder cell.Merged preceding 1 day, and drew neck to put to death mouse, the body surface sterilization and fixing after, cut tweezer with sterilization and start skin of abdomen, the exposure peritonaeum from venter posterior.Sterilize with cotton ball soaked in alcohol wiping peritonaeum.To the abdominal cavity, washing fluid is reclaimed in flushing repeatedly with injector to inject 10ml RPMI RPMI-1640, and centrifugal 10 minutes of 1000r/min abandons supernatant.With the resuspended precipitation of RPMI RPMI-1640 that contains 20% foetal calf serum, adjusting cell concn is 2 * 10
5/ ml.Above-mentioned cell suspension is added 96 orifice plates, and every hole 0.1ml puts 37 ℃, 6%CO
2Incubator in overnight incubation.
B) preparation of immune spleen cell
Get the BALB/c mouse after immunity is finished, by the neck dislocation mouse that causes death, be soaked in 75% alcohol 5 minutes, aseptic condition takes out spleen down, and in plate, the RPMI RPMI-1640 cleans 1 time.Spleen is moved in another plate that fills 10ml RPMI RPMI-1640, make splenocyte enter nutrient solution.With suction pipe piping and druming for several times.Filter, the results splenocyte suspension, centrifugal 10 minutes of 1000r/min uses RPMI RPMI-1640 centrifuge washing 2 times, and then that cell is resuspended, counting is used for cytogamy.
C) myeloma cell
Before merging 48-36 hour, with myeloma cell's enlarged culturing, cell is blown down gently from the bottle wall on fusion same day with the elbow dropper, be collected in the 50ml centrifuge tube.Centrifugal 10 minutes of 1000r/min, supernatant discarded.Add the incomplete substratum of 30ml, once with the method centrifuge washing.Then cell is resuspended to the incomplete substratum of 10ml, mixing.Get myeloma cell's suspension, counting is used for cytogamy.
D) cytogamy and HAT select hybridoma
Myeloma cell and immune spleen cell are pressed 1: 10 mixed, in the 50ml centrifuge tube, wash 1 time with the RPMI1640 nutrient solution, 1200r/min, centrifugal 10min abandons supernatant, with the careful sucking-off residual liquid of dropper.At the bottom of touching fusion pipe on the palm, make sedimentation cell loose evenly, put preheating in 40 ℃ of water-baths.Adding is preheated to 40 ℃ 50%PEG (PH 8.0) 1ml in the time of 45 seconds, acts on 90 seconds.Add 20ml and be preheated to 37 ℃ RPMI RPMI-1640, room temperature left standstill 10 minutes.1000r/min, centrifugal 5min, supernatant discarded.Add 5ml HAT substratum, the pressure-vaccum sedimentation cell suspends and mixing it gently, add then contain feeder cell the HAT substratum to 80ml.Packing 96 porocyte culture plates, every hole 0.1ml puts culture plate 37 ℃, 6%CO then
2Cultivate in the incubator.
With HAT substratum 1/2 substratum that swaps out, change liquid after 48 hours fully after 24 hours.Two week backs are with the HT substratum HAT substratum that swaps out, kept for two weeks again after, use the RPMI RPMI-1640 instead.
4. hybridoma screening
After hybridoma merged for two weeks, carry out hybridoma screening according to the routine immunization zymotechnic.Filter out the hybridoma hole that to secrete anti-African swine fever virus antibody.
5. the cloning of hybridoma and frozen
A) clone of hybridoma
The cloning scheme is a limiting dilution assay, carries out according to conventional hybridization oncocyte cloning process, and the clone carries out three times with method.
B) hybridoma is frozen
Cells frozen storing liquid: 50% calf serum+40%RPMI RPMI-1640+10% dimethyl sulfoxide (DMSO)
Hybridoma is centrifugal, be suspended in again in the frozen storing liquid of precooling, concentration is 106-107/ml, is transferred in the frozen pipe every bottle of 1ml.Place-70 ℃ of refrigerators, change in the liquid nitrogen next day.
The hybridoma cell line of preparation anti-African swine fever virus monoclonal antibody is preserved in the common micro-organisms center C GMCC NO.3750 of China Committee for Culture Collection of Microorganisms, preservation day: 2010-04-22, classification name: hybridoma cell strain.
Two, Monoclonal Antibody
Among the present invention, the scheme of mass production monoclonal antibody is the mouse ascites method, and step is as follows:
This programme is inoculated in the hybridoma of above-mentioned acquisition in the mouse peritoneal, the hybridoma of in mouse peritoneal, growing, and produce ascites, obtain a large amount of ascites monoclonal antibodies.
Concrete grammar is: BALB/c mouse abdominal cavity inoculation liquid paraffin body, every mouse 0.5ml.After two weeks, the hybridoma that the abdominal cavity inoculation is diluted with serum free medium, every mouse 5 * 10
5/ 0.2ml.At interval after 5 days, observe the mouse ascites production every day, when treating that the many as far as possible and mouse of ascites is on the verge of death, put to death mouse, under the aseptic condition with the ascites sucking-off.The static 30min of room temperature, 1000r/min, centrifugal 10min collects supernatant, packing ,-70 ℃ are frozen standby.
Three, monoclonal antibody purifying and horseradish peroxidase mark
1. Purification of Monoclonal Antibodies
The purification scheme of the ascites monoclonal antibody of above-mentioned acquisition is sad-ammonium sulfate precipitation method.
Get 1 part of pretreated ascites and add 2 parts of 0.06mol/L PH5.0 acetate buffer solutions, transfer PH to 4.8 with 1mol/LHCl; Add the sad ratio of 11ul in every milliliter of dilution ascites, it is sad dropwise to add under the stirring at room, adds in 30 minutes, and 4 ℃ left standstill 2 hours, took out the centrifugal 30min of 12000r/min, abandoned precipitation; Supernatant filters (125um) through nylon mesh, adds the 0.01mol/L PBS of 1/10 volume, transfers PH to 7.2 with 1mol/L NaOH; Add saturated ammonium sulphate to 45% saturation ratio down at 4 ℃, mixing 30min left standstill 1 hour gently; Centrifugal 30 minutes of 12000r/min abandons supernatant; Precipitation is dissolved among an amount of PBS, and to the PBS dialysis of 50-100 times of volume, 4 ℃ are spent the night; Take out the centrifugal 30min of 12000r/min, remove infusible precipitate, packing, frozen standby.
2. the horseradish peroxidase mark of monoclonal antibody
The preparation scheme of the enzyme labelling thing of the monoclonal antibody behind the purifying is the sodium periodate method, and concrete steps are as follows:
Taking by weighing 5mg HRP is dissolved in the 1ml distilled water; To wherein adding the 0.1MNaIO that 0.2ml newly joins
4Solution, the room temperature lucifuge stirred 20 minutes; Dialyse in the sodium-acetate buffer to 1mM pH4.4,4 ℃ are spent the night; Carbonate buffer solution to wherein adding 20 μ l 0.2M pH9.5 again makes the pH of above hydroformylation thing be elevated to 9.0, adds the pure product 5mg of monoclonal antibody (10mg/ml) that is dissolved in the 0.01M carbonate buffer solution then immediately, and the room temperature lucifuge is soft to be stirred 2 hours; Add the 4mg/ml NaBH that 0.1ml newly joins
4, mixing was placed 2 hours for 4 ℃; Products therefrom is to 4 ℃ of dialysed overnight among the 0.15M pH7.4PBS.
The dialysis finish after, in stirring, dropwise add the equal-volume saturated ammonium sulphate, put 4 ℃ 1 hour.The centrifugal 30min of 3000r/min abandons supernatant.Throw out is washed secondary with semi-saturation ammonium sulfate, and last throw out is dissolved among the PBS of a small amount of 0.15M pH 7.4.Above-mentioned solution is packed in the dialysis tubing, to the PBS damping fluid dialysis of 0.15M pH7.4, take out ammonium ion, the centrifugal 30min of 10000r/min removes precipitation, and supernatant liquor is enzyme conjugates, and is after the packing, frozen.
Four, the preparation of standard A SFV positive serum and standard A SFV negative serum
In the ELISA testing process, can there be certain error between different operator and different detections batch, operate miss can cause the error of test sample OD value.The present invention has developed standard A SFV antibody positive control serum and standard A SFV negative antibody control serum, is used for the optimization of testing conditions and the judgement of detected result.
A) preparation of standard positive serum
Get the healthy adult rabbit, body weight 2-3kg cuts off the part rabbit hair of two hind paws, uses iodine disinfection skin.Immunity is drawn not formula Freund's complete adjuvant (FCA) emulsive antigen (P54 recombinates behind the purifying) (to call FCA-P54 in the following text) liquid 1ml with syringe for the first time, the subcutaneous 0.5ml that injects of every batter palm.At interval after 10-14 days, carry out immunity second time, and inject not formula Freund (FIA-P54) in the lymphoglandula of Liang Ce popliteal nest and groin enlargement, each lymphoglandula 0.1ml, all the other inject near the subcutaneous 1ml of being total to lymphoglandula.After 7-10 days, from ear vein blood sampling 0.5-1.0ml, separation of serum adopts the ELISA method to detect serum titer at interval, and antibody titer can reach more than 1: 100.
Adopt the blood sampling of heart blood-collecting method, the blood that extracts is injected aseptic Erlenmeyer flask immediately.The blood of Erlenmeyer flask is put 37 ℃ of incubators 1 hour, put 4 ℃ of refrigerators again 3 hours.After treating the blood coagulation blood clot retraction, draw serum with dropper, the centrifugal 15min of 3000r/min gets supernatant, and it is anticorrosion to add final concentration and be 0.01% Thiomersalate, after the packing, and-20 ℃ of preservations.
B) preparation of standard female serum
The SPF rabbit of learning from else's experience and being up to the standards, heart blood sampling, separation of serum, add ten thousand/ Thiomersalate anticorrosion.Be sub-packed in the sterile tube-20 ℃ of preservations with 0.5ml.
Five, the foundation of test kit
A) the detection principle of test kit of the present invention
Adopt competition law, the African swine fever virus structural protein P54 that recombinates is wrapped by in microwell plate, with 1%BSA enzyme plate is sealed then, add sample to be tested and standard positive control, negative control.The P54 antigen-reactive of bag quilt in African swine fever virus antibody capable in sample or the standard substance and the enzyme plate adds at the competition that participates in behind the monoclonal antibody linked with peroxidase of P54 in conjunction with epi-position.Subsequently, add horseradish peroxidase substrate TMB colour developing, the stop buffer termination reaction, by microplate reader under the 450nm wavelength, measure each hole absorbance, the content of African swine fever virus antibody is inversely proportional in size of OD value (depth of color development stopping reaction back color) and the sample to be tested.
B) composition of test kit of the present invention
A) the best preparation method of enzyme plate
Carbonate buffer solution with pH9.60.05M is cushioned liquid as bag, after reorganization P54 albumen dilution behind the purifying of above-mentioned preparation, presses the 100ul/ hole and adds in the microwell plate, guarantees that the P54 content in every hole is 0.2ug.4 ℃ of bags are spent the night, and discard coating buffer next day, press the confining liquid that the 200ul/ hole adds 1%BSA, and 37 ℃ left standstill 2 hours, and washing dries.The packing bag of packing into after the drying at room temperature adds siccative, and vacuum is preserved.
B) configuration of work reagent
Washings (pH 7.4,0.15M PBS): KH
2PO
40.2g, Na
2HPO
4-12H
2O 2.9g, NaCl 8.0g, KCl 0.2g, Tween-20 (0.05%) 0.5ml, adding distil water is to 1000ml.Be condensed into 25 times as storage liquid.
Serum dilution: bovine serum albumin 0.1g adds lavation buffer solution to 100ml
Substrate buffer solution (pH 5.0 phosphoric acid citric acids): 0.2M Na
2HPO
425.7ml, 0.1M citric acid 24.3ml, adding distil water 50ml
TMB (tetramethyl benzidine) uses liquid: TMB (10mg/5ml dehydrated alcohol) 0.5ml, substrate buffer solution 10ml, 0.75%H
2O
232ul
Stop buffer (2M H
2SO
4): distilled water 178.3ml dropwise adds the vitriol oil (98%) 21.7ml
C) establishment of the competitive ELISA kit of detection African swine fever
Set up the enzyme linked immunological kit that detects African swine fever, comprise following component:
96 hole enzyme plates
The monoclonal antibody of horseradish peroxidase-labeled
Standard positive control
Standard negative control
Concentrated cleaning solution
Serum dilution
Tmb substrate
Stop buffer
Product description
Six, African swine fever virus detection of antibodies in the sample
A) test kit with above-mentioned preparation detects
1) test serum, positive control and negative control are diluted in proportion with antibody diluent, every hole 100 μ l add enzyme plate, hatch 1 hour for 37 ℃.Washings cleans 3-5 time.
2) every hole adds dilution back monoclonal antibody linked with peroxidase 100 μ l, hatches 30min for 37 ℃, and washings cleans 3-5 time.
3) every hole adds tmb substrate liquid 100 μ l, room temperature lucifuge reaction 10-15 minute.
4) every hole adds 100 μ l 2M H
2SO
4Termination reaction, microplate reader detects the 450nm absorbance.(lab diagram is seen accompanying drawing 3)
B) detected result analysis
When the OD value of negative control sera (NC) was 4 times of positive control serum (PC) at least in i. surveying, detection was considered to effective.(experimental data sees Table 2)
Table 2 adopts ELISA test kit of the present invention to detect sample African swine fever antibody data
| 1 | 2 | 3 | 4 | 5 | 6 | |
| A | Negative control 1.483 | Negative control 1.417 | 0.195 | 0.196 | Negative serum 1.215 | Negative serum 1.223 |
| B | Positive control 0.145 | Positive control 0.154 | 0.229 | 0.219 | Negative serum 1.158 | Negative serum 1.201 |
| C | 0.215 | 0.227 | 0.34 | 0.328 | Negative serum 1.121 | Negative serum 1.159 |
| D | 0.203 | 0.204 | 0.531 | 0.518 | Negative serum 1.106 | Negative serum 1.152 |
| E | 0.183 | 0.185 | Suspicious sample 0.797 | Suspicious sample 0.813 | ||
| F | 0.184 | 0.177 | Negative serum 1.035 | Negative serum 1.067 | ||
| G | 0.184 | 0.18 | 0.21 | 0.202 | ||
| H | 0.191 | 0.192 | Negative serum 1.201 | Negative serum 1.195 |
NC/PC≥4
Positive Cut Off=NC-[(NC-PC) * 0.5]
Negative Cut Off=NC-[(NC-PC) * 0.4]
NC=negative control sera OD value wherein
PC=positive control serum OD value
Data computation in the his-and-hers watches 2, drawing positive Cut Off is 0.800, negative Cut Off is 0.930.
Use multiple hole when ii. detecting, finally using the OD value is two mean value.
When the OD of serum sample value was lower than positive Cut Off value, this sample was the ASFV antibody positive.
When the OD of serum sample value is higher than negative Cut Off value is that this sample is the ASFV negative antibody.
When the OD of serum sample value is between two Cut Off values, be considered to suspicious, should test again for this sample, perhaps adopt other detection methods to confirm.
In sum, content of the present invention is not limited in the above-described embodiment, and the knowledgeable people in the same area can propose other embodiment easily within technical director's thought of the present invention, but this embodiment comprises within the scope of the present invention.
Claims (3)
1. a hybridoma cell line of secreting anti-African swine fever virus monoclonal antibody is characterized in that, the preserving number of described clone is CGMCC NO.3750.
2. the hybridoma cell line of secretion anti-African swine fever virus monoclonal antibody according to claim 1, it is characterized in that described hybridoma cell line is set up as immunogen with prokaryotic expression recombinant solubility African swine fever virus P54 albumen by hybridoma technology.
3. the described hybridoma cell line excretory of claim 1 anti-African swine fever virus monoclonal antibody.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010154062XA CN101818129B (en) | 2010-04-23 | 2010-04-23 | Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010154062XA CN101818129B (en) | 2010-04-23 | 2010-04-23 | Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101818129A CN101818129A (en) | 2010-09-01 |
| CN101818129B true CN101818129B (en) | 2011-11-02 |
Family
ID=42653407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010154062XA Expired - Fee Related CN101818129B (en) | 2010-04-23 | 2010-04-23 | Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101818129B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103172749B (en) * | 2013-02-01 | 2014-10-08 | 广州谱泰生物技术有限公司 | Preparation of African swine fever protein engineering vaccine |
| CN103293306B (en) * | 2013-05-22 | 2015-04-08 | 扬州大学 | Preparation method for African swine fever virus antibody detection colloidal gold immunochromatography test paper strip |
| CN104262484A (en) * | 2014-10-17 | 2015-01-07 | 深圳出入境检验检疫局动植物检验检疫技术中心 | Specific IgY antibody for resisting African swine fever virus as well as preparation method and application thereof |
| CN104497136B (en) * | 2014-12-05 | 2017-10-31 | 深圳出入境检验检疫局动植物检验检疫技术中心 | African swine fever virus gene II type strain monoclonal antibodies and preparation method and application |
| CN104497137B (en) * | 2014-12-05 | 2017-10-31 | 深圳出入境检验检疫局动植物检验检疫技术中心 | The general monoclonal antibody of African swine fever virus strain and preparation method and application |
| CN107937349B (en) * | 2017-11-27 | 2021-01-15 | 中国检验检疫科学研究院 | Cell line for stably expressing African swine fever virus P54 protein and preparation and application thereof |
| CN111549001B (en) * | 2020-05-28 | 2024-04-19 | 嘉铭(固安)生物科技有限公司 | Hybridoma cell strain secreting African swine fever virus p34 protein monoclonal antibody, monoclonal antibody and application |
| CN111849922B (en) * | 2020-07-20 | 2021-08-03 | 华中农业大学 | Monoclonal antibody prepared from African swine fever virus truncated protein p54 and application thereof |
| CN112481220B (en) * | 2020-11-03 | 2021-09-14 | 中国农业科学院兰州兽医研究所 | anti-African swine fever virus helicase D1133L monoclonal antibody, hybridoma cell strain secreting monoclonal antibody and application |
| CN113278066B (en) * | 2021-05-25 | 2021-12-14 | 中国农业科学院兰州兽医研究所 | Full-swine-origin African swine fever virus monoclonal antibody and preparation method thereof |
| CN113402601A (en) * | 2021-06-09 | 2021-09-17 | 河南中泽生物工程有限公司 | Preparation method and application of anti-African swine fever virus p54 protein monoclonal antibody |
-
2010
- 2010-04-23 CN CN201010154062XA patent/CN101818129B/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| Covadonga et al.African Swine Fever Virus Protein p54 Interacts with the Microtubular Motor Complex through Direct Binding to Light-Chain Dynein.《Journal of Virology》.2001,第75卷(第20期),9819-9827. * |
| PAULINO et al.Neutralizing Antibodies to Different Proteins of African Swine Fever Virus Inhibit both Virus Attachment and Internalization.《Journal of Virology》.1996,第70卷(第8期),5689-5694. * |
| Paulino et al.The African Swine Fever Virus Proteins p54 and p30 Are Involved in Two Distinct Step of Virus Attachment and Both Contribute to the Antibody-Mediated Protective Immune Response.《Virology》.1998,第243卷467-471. * |
| 朱红.非洲猪瘟病毒P72蛋白单克隆抗体的制备及抗体检测方法的建立.《中国优秀硕士学位论文全文数据库 农业科技辑》.2007,(第06期),D050-352. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101818129A (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101818129B (en) | Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby | |
| CN101831407B (en) | Hybridoma cell line of monoclonal antibody against African swine fever virus and secreted monoclonal antibody thereof | |
| CN101833005B (en) | Competitive ELISA (Enzyme-Linked Immuno Sorbent Assay) kit for detecting antibody of African swine fever virus and application thereof | |
| CN101825633B (en) | Competitive ELISA kit for detecting african swine fever virus antibody and purposes thereof | |
| CN102236017A (en) | Indirect ELISA kit for detecting African swine fever virus antibody and application thereof | |
| CN101294147B (en) | Monoclone antibody of swine fever virus resistant wild strain E2 protein, preparation method and application thereof | |
| CN102236019A (en) | Indirect ELISA kit for detecting African swine fever virus | |
| CN101915846A (en) | ELISA kit for detecting porcine reproductive and respiratory syndrome virus and using method | |
| CN113740536B (en) | African swine fever virus p30 blocking ELISA antibody detection kit and application thereof | |
| CN103033626B (en) | Colloidal gold strip for TGEV antibody and PEDV antibody | |
| CN107058239A (en) | A kind of swine fever virus resistant E2 protein monoclonal antibodies cell line and its application | |
| CN106336458A (en) | Vibrio parahaemolyticus colloidal gold-yolk antibody rapid detection test paper and preparation method thereof | |
| CN1996020A (en) | Double-antibody sandwich enzyme-linked immunologic adsorption detection kit for cucumber mosaic virus and method for preparing same | |
| CN102242083B (en) | 3D protein monoclonal antibody for resisting novel duck hepatitis virus serotype I | |
| CN105548550A (en) | Immunofluorescence reagent for detecting E-type enterovirus and detection kit thereof | |
| CN108752471A (en) | The preparation method and applications of anti-PCV2 monoclonal antibodies | |
| CN101781656A (en) | Expression of odontoglossum ringspot virus (ORSV) coat protein gene and preparation method of antibody | |
| CN101921337B (en) | Antibody against lactate dehydrogenase of plasmodium vivax, related preparation method, hybridoma cell strain and application | |
| CN1996019A (en) | Double-antibody sandwich enzyme-linked immunologic adsorption detection kit for lily symtomless virus and method for preparing same | |
| CN101671655A (en) | Monoclonal antibody hybridoma cell of HIV P24 and application | |
| CN103361317B (en) | Macaque IFN-gamma (interferon-gamma) monoclonal antibody hybridoma as well as preparation method and application thereof | |
| CN103044544A (en) | ELISA (enzyme-linked immunosorbent assay) kit for detecting highly pathogenic PRRSV (porcine reproductive and respiratory syndrome virus) and application thereof | |
| CN102690351A (en) | Preparation method of plasmodium vivax aldolase protein monoclonal antibody | |
| CN102229915A (en) | EV71 virus monoclonal antibody, hybridoma cell line and application | |
| CN104130326A (en) | Monoclonal antibody of Chlamydophila abortus macrophage infectivity potentiator and hybridoma cell thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111102 Termination date: 20130423 |